Addex Therapeutics Ltd
Biotechnology
Healthcare
ADXN
820 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
10.23
52 week high
11.58
high
10.23
52 week low
0.00
low
9.03
growth
-8.23 %
previous Close
9.66
P/E ratio
-5
market cap
9.79 M
div yield
0
usd
Mar 2025
qoq
revenue
1.51 K
-97.20 %
net incoming
-1.47 M
3.73 %
eps
-2.00 %
-119.66 %
eps surprise
0.00 %
net profit margin
-97669.96 %
-94828.00 %
operating incoming
-606.26 K
2.56 %
net change in cash
-516.25 K
-17.70 %
cash on hand
2.83 M
-15.64 %
cost of revenue
0.00 %
top top